FDA

UPDATE: Federal Contractor Vaccine Mandate

Federal Contractors are being given additional time and flexibility to address the vaccination mandate – Employees must be fully vaccinated by January 18, 2022.   The Department of Health and Human Services (HHS) and The United States Department of Agriculture (USDA) Contracting Officers Have Enormous Discretion To Add Vaccine Mandate Clause to Product Contracts.   […]

UPDATE: Federal Contractor Vaccine Mandate Read More »

OSHA Releases ETS on Vaccine and Testing Mandate

On November 4, 2021, the Occupational Safety and Health Administration’s (OSHA) released the prepublished version of its expected new emergency temporary standard (ETS). The OSHA ETS (interim final rule; request for comments) was published in the Federal Register on November 5, 2021. The OSHA ETS requires employers with 100 or more employees to mandate that all their

OSHA Releases ETS on Vaccine and Testing Mandate Read More »

October Food and Agriculture Regulatory Recap

OFW’s Food & Agriculture team regularly monitors announcements and policy issuances from FDA, USDA, and other agencies to keep our clients apprised of regulatory developments that may impact their business. Here are a few of the developments from October that we took note of. If you have any questions or would like more information, please

October Food and Agriculture Regulatory Recap Read More »

FDA Notice of Proposed Rulemaking: Proposed Repeal of HHS Rules on Guidance, Enforcement, and Adjudication Procedures

On October 20, the United States Department of Health and Human Services (HHS) published a Notice of Proposed Rulemaking that would, in relevant part, repeal a Trump Administration rule on, “Department of Health and Human Services Good Guidance Practices,” (GGP Rule) (Dec 7, 2020).    The GGP Rule required: Each guidance document issued by HHS

FDA Notice of Proposed Rulemaking: Proposed Repeal of HHS Rules on Guidance, Enforcement, and Adjudication Procedures Read More »

FDA Announces a DSCSA Public Meeting and Requests Comments

The United States Food and Drug Administration (FDA) announced that it will be virtually hosting a public meeting on November 16, 2021, on Drug Supply Chain Security Act (DSCSA) implementation.  The purpose of this meeting is to allow interested stakeholders the opportunity to provide input to the FDA on the enhanced drug distribution security provisions

FDA Announces a DSCSA Public Meeting and Requests Comments Read More »

OFW Law to co-host the 2021 Food Labeling Summit with the Food Institute next month

Next month, The Food Institute kicks off its 3-day virtual training seminar on Food Labeling and Olsson Frank Weeda Terman Matz PC will be co-hosting the event. Each day has its own unique theme. On day one, attendees may expect to first learn the basics of the Food and Drug Administration’s (FDA) and the U.S.

OFW Law to co-host the 2021 Food Labeling Summit with the Food Institute next month Read More »

FTC to Issue Final Rule to Combat “Made in USA” Fraud

On July 1st, the Federal Trade Commission voted 3-2 to publish the final Made in USA Labeling Rule in the Federal Register.  The rule is consistent with – and essentially codifies – its prior 1997 Enforcement Policy Statement on U.S. Origin Claims, and provides the agency with enforcement tools to combat fraudulent claims.   The rule

FTC to Issue Final Rule to Combat “Made in USA” Fraud Read More »

Long-Awaited DSCSA Guidances Published

On June 3, the Food and Drug Administration (FDA) released four  guidances implementing the Drug Supply Chain Security Act (DSCSA). Final Guidance for Industry: Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification  (Suspect Product Final Guidance) Final Guidance for Industry: Product Identifiers under the Drug Supply Chain Security Act – Questions

Long-Awaited DSCSA Guidances Published Read More »

FDA Reverses Trump Administration’s Unapproved Drugs Policy

On May 26, the Food and Drug Administration (FDA) reversed a Trump Administration policy that revoked the agency’s longstanding Unapproved Drugs Initiative (UDI).  On November 15, 2020, then HHS Secretary Alex Azar issued a notice and a request for information entitled “Termination of the Food and Drug Administration’s Unapproved Drugs Initiative; Request for Information Regarding

FDA Reverses Trump Administration’s Unapproved Drugs Policy Read More »

FDA Reverses a Trump Administration Drug Review Transparency Policy

On April 30, the Food and Drug Administration (FDA) reversed a  Policy issued by the Department of Health and Human Services (HHS) near the end of the Trump Administration that was purportedly intended to increase drug review timeline transparency.  The Policy was announced in the Federal Register on January 15 and would have required FDA

FDA Reverses a Trump Administration Drug Review Transparency Policy Read More »

The American Rescue Plan Act of 2021—What’s in It for CDC and FDA?

On March 10, the House passed the Senate-amended version of the American Rescue Plan Act of 2021 (H.R. 1319), a $1.9 trillion COVID-19 relief package intended to address the impact of the pandemic on the economy, state and local governments, and individuals.  The package contains public health provisions intended to boost COVID testing and contact

The American Rescue Plan Act of 2021—What’s in It for CDC and FDA? Read More »

CDRH Cracks Down on Misleading “Registration Certificates”

On March 3, Rear Admiral Sean Boyd, Director of the Office of Regulatory Programs at the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) announced an uptick in firms selling and issuing fraudulent “FDA registration certificates” which indicate that a medical device has been authorized, approved, cleared, or reviewed by the

CDRH Cracks Down on Misleading “Registration Certificates” Read More »

A big pile of bulk blue medical masks

FDA Issues Warning Letters Targeting COVID-19 (and other) Products

Since the COVID-19 pandemic began to intensify in March 2020, the Food and Drug Administration (FDA) has sent warning letters to 146 manufacturers of products claiming to prevent, treat, mitigate, diagnose or cure coronavirus.  These products range from teas, tinctures, test kits, soaps, supplements, and CBD products.  In January, the FDA’s Office of Criminal Investigations

FDA Issues Warning Letters Targeting COVID-19 (and other) Products Read More »

Candidates Emerge to Lead FDA

As the Biden Administration settles into Washington and works to address the COVID-19 pandemic, many medical products and food safety stakeholders wonder who will lead the Food and Drug Administration.  Janet Woodcock, M.D. who long led the Center for Drug Evaluation and Research (CDER) and advised “Operation Warp Speed” on COVID-19 therapeutics currently serves as

Candidates Emerge to Lead FDA Read More »

Food and Drug Administration building

FDA Funding in the Energy & Commerce Reconciliation Bill

House Energy & Commerce Committee Chairman Frank Pallone (D-NJ) announced that the committee will hold a markup on Thursday at 11:00 AM ET to consider legislative recommendations for its budget reconciliation instructions.  Section 3004 of the bill provides $500 million to the Food and Drug Administration to combat the COVID-19 pandemic by: Supporting the review

FDA Funding in the Energy & Commerce Reconciliation Bill Read More »

Carbon Labeling: Who is Ahead of the Game?

With climate change discussions being elevated on a local, regional, and global scale, many individuals are considering how their personal choices, including foods they consume, impact the environment. This has translated to a resurgence of interest in carbon labeling food products. Now that we understand the basics of carbon labeling and what it means for

Carbon Labeling: Who is Ahead of the Game? Read More »

How Does Buying American Benefit U.S. Food, Agriculture, and Medical Products?

President Biden recently issued an Executive Order (EO) to harness the federal government’s purchasing power to bolster domestic manufacturing. The “Strengthening Buy American Provisions, Ensuring Future of America is Made in America by All of America’s Workers” intends to support American industry and American workers. Overall, this EO looks to close loopholes in existing “Buy American” policies

How Does Buying American Benefit U.S. Food, Agriculture, and Medical Products? Read More »

Register by October 1 to receive $100 discount on OFW/Food Institute Virtual Food Labeling Course

OFW and The Food Institute will be holding their annual Food Labeling Seminar on October 7, 8, and 9.  The virtual training course will cover everything you need to know about food labeling in today’s marketplace.  The course will first cover basics of FDA’s and USDA’s food labeling requirements, including recent updates.  The seminar will then

Register by October 1 to receive $100 discount on OFW/Food Institute Virtual Food Labeling Course Read More »

QHC for Cranberry Products and Reduced Risk of Recurrent Urinary Tract Infection in Healthy Women

FDA has published a letter of enforcement discretion, which it sent to legal counsel for Ocean Spray Cranberries, Inc., that authorizes a qualified health claim (QHC) for specific cranberry products when consumed in specific amounts by specific people.  The substantiation for the diet-disease relationship warranted a “limited and inconsistent” or “limited” scientific evidence qualifier. Based

QHC for Cranberry Products and Reduced Risk of Recurrent Urinary Tract Infection in Healthy Women Read More »

2020 Dietary Guidelines Near the End of Stage One

By: Julia Johnson On Wednesday, June 16, the 2020, the Dietary Guidelines Advisory Committee (DGAC) hosted a public meeting to review their draft scientific report. A new edition of the Dietary Guidelines for Americans is published every 5-years and developed in three stages: (I) Reviewing the science; (II) developing the guidelines; (III) implementation. The most

2020 Dietary Guidelines Near the End of Stage One Read More »

FDA Guidance: Enforcement Discretion Under the Qualified Exemption Provisions of the Produce Safety Rule

The U.S. Food and Drug Administration (FDA) has published an announcement of the availability of a Guidance Document, Temporary Policy During the COVID-19 Public Health Emergency Regarding the Qualified Exemption from the Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption (May 2020).  Comments on the Guidance may be submitted to

FDA Guidance: Enforcement Discretion Under the Qualified Exemption Provisions of the Produce Safety Rule Read More »

OFW’s John G. Dillard and Mason Weeda to Present the Food Institute’s COVID:19 Webinar on May 12

On May 12, OFW Principals, John G. Dillard and Mason Weeda will be presenting a webinar in collaboration with The Food Institute on the U.S. regulatory response in connection to the novel coronavirus crisis. The focus will be on the policies and practices implemented by USDA, FDA, OSHA, Department of Homeland Security, and Department of

OFW’s John G. Dillard and Mason Weeda to Present the Food Institute’s COVID:19 Webinar on May 12 Read More »

Cows relaxing in the meadow

COVID-19 Webinar: Federal Regulatory Changes Impacting the Food Industry – Recording Available

On April 22, OFW Principal John Dillard presented a webinar addressing the federal regulatory changes that have been implemented to respond to the COVID-19 pandemic. The webinar also discussed guidance from USDA, FDA, the Department of Homeland Security, and the Center for Disease Control as well as some of the best practices that have been

COVID-19 Webinar: Federal Regulatory Changes Impacting the Food Industry – Recording Available Read More »

John Dillard to Present Free Webinar on COVID-19 and Regulatory Changes Affecting the Food Industry

John G. Dillard, a principal at OFW. will be presenting a review of several federal agencies’ responses to the COVID-19 crisis that affect food producers and manufacturers. The webinar, “COVID-19: Regulatory Changes Impacting Food Production and Distribution” will be offered by the National Agricultural Law Center on Wednesday, April 22, 2020 at 12pm EST. John

John Dillard to Present Free Webinar on COVID-19 and Regulatory Changes Affecting the Food Industry Read More »

Male hand hand holding Q&A word with wooden cube block

FDA COVID-19 Food Safety Q&A

The FDA is currently posting updates in a Q&A format on its Food Safety and the Coronavirus Disease 2019 (COVID-19) webpage.  The Q&A provides information to food production/processing facilities and retail food establishments regarding best practices during the ongoing public health emergency.  For example, the website provides some salient advice on social distancing in food

FDA COVID-19 Food Safety Q&A Read More »

fresh eggs in a cardboard tray

Complete Label Exemption for Shell Eggs During Pandemic

Today the FDA issued a guidance to provide temporary flexibility regarding the packaging and labeling of shell eggs sold to consumers in retail food establishments.  Temporary Policy Regarding Packaging and Labeling of Shell Eggs Sold by Retail Food Establishments During the COVID-19 Public Health Emergency: Guidance for Industry (Apr. 2020) The guidance essentially permits retailers

Complete Label Exemption for Shell Eggs During Pandemic Read More »

woman looking at menu at restaurant

Menu Labeling Flexibility for Covered Establishments During Pandemic

The Food and Drug Administration (FDA) has issued a guidance to chain restaurants and similar retail food establishments (“covered establishments”) that sell standard menu items covered under the menu labeling provisions of section 403(q)(5)(H) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) to provide flexibility regarding these menu labeling requirements during the COVID-19

Menu Labeling Flexibility for Covered Establishments During Pandemic Read More »

silver food packaging on a wooden background

New Guidance Documents from the FDA on Foods Labeling and Postponement of Compliance Date for Revised Nutrition/Supplement Facts Panels

On Friday, the Food and Drug Administration (FDA) announced the issuance of a new Guidance document pertaining to nutrition labeling during the COVID-19 health crisis. It is intended to provide restaurants and food manufacturers with flexibility regarding nutrition labeling so that they can sell certain packaged foods during the current pandemic.  This guidance does not

New Guidance Documents from the FDA on Foods Labeling and Postponement of Compliance Date for Revised Nutrition/Supplement Facts Panels Read More »

Feet in sneakers on top of arrow

FDA and CFSAN on Issuing Guidance Documents Concerning COVID-19

The Food and Drug Administration (FDA) published a Notice that set forth the process that it and the Center for Food Safety and Applied Nutrition (CFSAN) will use in expediting the availability of guidance documents concerning the ongoing COVID-19 public health emergency. It will include essential recommendations and policies and will eliminate requisite notice and

FDA and CFSAN on Issuing Guidance Documents Concerning COVID-19 Read More »

A big pile of bulk blue medical masks

Defense Production Act Update – 3/23/2020

Today, the President signed an Executive Order to authorize the Sec. of HHS to designate medical equipment as “critical” or “essential” to the national response to the crisis. Under DPA § 102, the President can take action to prohibit the hording of materials designated as “scarce” or “essential.” Sec. 102 prohibits the accumulation of such

Defense Production Act Update – 3/23/2020 Read More »

Testing materials for COVID 19 Corona Virus

COVID-19 Update for Diagnostic Device Manufacturers

The availability of Coronavirus Disease-2019 (COVID-19) diagnostic tests is critical to an effective response to the current pandemic. FDA has taken measures to permit the distribution of such tests in advance of receiving authorization to do so from the agency in an attempt to remove bureaucratic barriers that could affect the nation’s ability to mount

COVID-19 Update for Diagnostic Device Manufacturers Read More »

Initial NFP Compliance Date – 6 Months Enforcement Discretion

In response to requests received from multiple stakeholders, FDA has agreed, in effect, to exercise enforcement discretion relative to the new Nutrition Facts panel (NFP) for six months following the initial January 1, 2020 compliance date.  The agency is doing so through a new Question and Answer (Q&A) in the Compliance section of its Industry

Initial NFP Compliance Date – 6 Months Enforcement Discretion Read More »

FDA Publishes Draft Guidance For Sprout Seed Producers

Sprouts are associated with numerous foodborne illness outbreaks. According to the U.S. Food and Drug Administration (FDA), more than 2,600 documented illnesses have been associated with consuming contaminated sprouts since 1996. Much of the challenge to controlling risks lies in the fact that seeds are often the source of contamination in sprout products. In FDA’s

FDA Publishes Draft Guidance For Sprout Seed Producers Read More »